SEC 13F Intelligence

Renaissance Technologies LLC / HTD

Renaissance Technologies LLC’s Corcept Therapeutics Inc Position

Does Renaissance Technologies LLC own Corcept Therapeutics Inc (HTD)? Yes — 5.68M shares worth $229M (+0.36% of its 13F portfolio) as of Q1 2026, down from 5.76M shares the prior filed quarter.

Position Value
$229M
Q1 2026
Shares
5.68M
% of Portfolio
+0.36%
Quarters Held
26
currently held

Position History HTD

Reported value by quarter
Q4 ’19: $94MQ4 ’19Q1 ’20: $99MQ2 ’20: $150MQ3 ’20: $167MQ4 ’20: $244MQ4 ’20Q1 ’21: $209MQ2 ’21: $187MQ3 ’21: $162MQ4 ’21: $159MQ4 ’21Q1 ’22: $175MQ2 ’22: $186MQ3 ’22: $185MQ4 ’22: $148,037Q4 ’22Q1 ’23: $147,030Q2 ’23: $149,074Q3 ’23: $180,222Q4 ’23: $218,456Q4 ’23Q1 ’24: $179,312Q2 ’24: $225MQ3 ’24: $301MQ4 ’24: $312MQ4 ’24Q1 ’25: $702MQ2 ’25: $460MQ3 ’25: $506MQ4 ’25: $200MQ4 ’25Q1 ’26: $229Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20265.68M$229M+0.36%
Q4 20255.76M$200M+0.31%
Q3 20256.09M$506M+0.67%
Q2 20256.27M$460M+0.61%
Q1 20256.14M$702M+1.06%
Q4 20246.20M$312M+0.46%
Q3 20246.51M$301M+0.45%
Q2 20246.91M$225M+0.38%
Q1 20247.12M$179,312+0.28%
Q4 20236.73M$218,456+0.34%
Q3 20236.61M$180,222+0.31%
Q2 20236.70M$149,074+0.21%
Q1 20236.79M$147,030+0.20%
Q4 20227.29M$148,037+0.20%
Q3 20227.20M$185M+0.26%
Q2 20227.83M$186M+0.22%
Q1 20227.77M$175M+0.21%
Q4 20218.02M$159M+0.20%
Q3 20218.25M$162M+0.21%
Q2 20218.52M$187M+0.23%
Q1 20218.77M$209M+0.26%
Q4 20209.34M$244M+0.27%
Q3 20209.61M$167M+0.17%
Q2 20208.92M$150M+0.13%
Q1 20208.30M$99M+0.10%
Q4 20197.77M$94M+0.07%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Renaissance Technologies LLC’s full portfolio or all institutional holders of HTD.